Group 1 - The core point of the article is that *ST Guohua announced a temporary board meeting to discuss a capital increase for Zhongshan Runle Pharmaceutical Co., Ltd. [1] - For the first half of 2025, *ST Guohua's revenue composition is as follows: mobile network security accounts for 82.23%, pharmaceutical technology services for 12.49%, others for 3.65%, and emergency industry for 1.64% [1] - As of the report date, *ST Guohua has a market capitalization of 1.6 billion yuan [1]

Core Viewpoint - *ST Guohua announced the convening of its 2025 seventh temporary board meeting, discussing the proposal for the first temporary shareholders' meeting of 2025, indicating ongoing corporate governance activities [1] Financial Performance - For the first half of 2025, *ST Guohua's revenue composition was as follows: mobile network security accounted for 82.23%, medical technology services for 12.49%, other services for 3.65%, and emergency industry for 1.64% [1] - The company's market capitalization is currently 1.4 billion yuan [1]